Register
Login:
Share:
Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018


Regulatory News


LYXOR RUSSELL 2000 UCITS ETF - C-USD Net Asset Value(s)

Fri, 10th Nov 2017 16:55


10-Nov-2017 / 16:55 GMT
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


Net Asset Value(s)

FUND: LYXOR RUSSELL 2000 UCITS ETF - C-USD

DEALING DATE: 09-Nov-2017

NAV PER SAHRE: USD: 208.3933

NUMBER OF SHARES IN ISSUE: 18700

CODE: RUS2 LN

ISIN: FR0011119254


(c) EQS Group Limited






Back to Regulatory News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.